Skip to content

Polaryx Therapeutics, Inc. PLYX Total Operating Expenses

Total Operating Expenses at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$12.32M+19.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$81.59M-11.8%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$227.59M+10.6%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-87.6%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's total operating expenses?
Polaryx Therapeutics, Inc. (PLYX) reported total operating expenses of $1.96M in Q1 2026.
How has Polaryx Therapeutics, Inc. 's total operating expenses changed year-over-year?
Polaryx Therapeutics, Inc. 's total operating expenses decreased by 61.2% year-over-year, from $5.05M to $1.96M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.